This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2013 Jul;64(1):173-6.

doi: 10.1016/j.eururo.2013.03.007. Epub 2013 Mar 14.

Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls

Zhiqun Shang, Shimiao Zhu, Hui Zhang, Lihua Li, Yuanjie Niu

PMID: 23518396
DOI: 10.1016/j.eururo.2013.03.007

Review

Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls

Zhiqun Shang et al. Eur Urol. 2013 Jul.

. 2013 Jul;64(1):173-6.

doi: 10.1016/j.eururo.2013.03.007. Epub 2013 Mar 14.

Authors

Zhiqun Shang, Shimiao Zhu, Hui Zhang, Lihua Li, Yuanjie Niu

PMID: 23518396
DOI: 10.1016/j.eururo.2013.03.007

No abstract available

PubMed Disclaimer

Similar articles

Association between germline HOXB13 G84E mutation and risk of prostate cancer.
Akbari MR, Trachtenberg J, Lee J, Tam S, Bristow R, Loblaw A, Narod SA, Nam RK. Akbari MR, et al. J Natl Cancer Inst. 2012 Aug 22;104(16):1260-2. doi: 10.1093/jnci/djs288. Epub 2012 Jul 9. J Natl Cancer Inst. 2012. PMID: 22781434
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R, Aly M, Clements M, Zheng L, Adolfsson J, Xu J, Grönberg H, Wiklund F. Karlsson R, et al. Eur Urol. 2014 Jan;65(1):169-76. doi: 10.1016/j.eururo.2012.07.027. Epub 2012 Jul 20. Eur Urol. 2014. PMID: 22841674
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z, Mikropoulos C, Leongamornlert DA, Dadaev T, Tymrakiewicz M, Saunders EJ, Jones M, Jugurnauth-Little S, Govindasami K, Guy M, Hamdy FC, Donovan JL, Neal DE, Lane JA, Dearnaley D, Wilkinson RA, Sawyer EJ, Morgan A, Antoniou AC, Eeles RA; UK Genetic Prostate Cancer Study Collaborators, and the ProtecT Study Group. Kote-Jarai Z, et al. Ann Oncol. 2015 Apr;26(4):756-761. doi: 10.1093/annonc/mdv004. Epub 2015 Jan 16. Ann Oncol. 2015. PMID: 25595936
Screening for familial and hereditary prostate cancer.
Lynch HT, Kosoko-Lasaki O, Leslie SW, Rendell M, Shaw T, Snyder C, D'Amico AV, Buxbaum S, Isaacs WB, Loeb S, Moul JW, Powell I. Lynch HT, et al. Int J Cancer. 2016 Jun 1;138(11):2579-91. doi: 10.1002/ijc.29949. Epub 2016 Feb 5. Int J Cancer. 2016. PMID: 26638190 Review.
[Update on genetic predisposition to prostate cancer].
Cussenot O, Cancel-Tassin G. Cussenot O, et al. Bull Cancer. 2015 Jan;102(1):53-6. doi: 10.1016/j.bulcan.2014.12.007. Epub 2014 Dec 29. Bull Cancer. 2015. PMID: 25609482 Review. French.

See all similar articles

Cited by

Validation of a Semiautomated Natural Language Processing-Based Procedure for Meta-Analysis of Cancer Susceptibility Gene Penetrance.
Deng Z, Yin K, Bao Y, Armengol VD, Wang C, Tiwari A, Barzilay R, Parmigiani G, Braun D, Hughes KS. Deng Z, et al. JCO Clin Cancer Inform. 2019 Aug;3:1-9. doi: 10.1200/CCI.19.00043. JCO Clin Cancer Inform. 2019. PMID: 31419182 Free PMC article.
HOXB13 and TFF3 can contribute to the prognostic stratification of prostate adenocarcinoma.
Timofte AD, Giuşcă SE, Lozneanu L, Manole MB, Prutianu I, Gafton B, Rusu A, Căruntu ID. Timofte AD, et al. Rom J Morphol Embryol. 2021 Jan-Mar;62(1):41-52. doi: 10.47162/RJME.62.1.04. Rom J Morphol Embryol. 2021. PMID: 34609407 Free PMC article.
Precision intervention for prostate cancer: Re-evaluating who is at risk.
Papachristodoulou A, Abate-Shen C. Papachristodoulou A, et al. Cancer Lett. 2022 Jul 10;538:215709. doi: 10.1016/j.canlet.2022.215709. Epub 2022 Apr 29. Cancer Lett. 2022. PMID: 35490919 Free PMC article. Review.
Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
Liu J, Prager-van der Smissen WJ, Schmidt MK, Collée JM, Cornelissen S, Lamping R, Nieuwlaat A, Foekens JA, Hooning MJ, Verhoef S, van den Ouweland AM, Hogervorst FB, Martens JW, Hollestelle A. Liu J, et al. Sci Rep. 2016 Jul 18;6:30026. doi: 10.1038/srep30026. Sci Rep. 2016. PMID: 27424772 Free PMC article.
Systematic meta-analyses of gene-specific genetic association studies in prostate cancer.
Hao Q, Wei D, Zhang Y, Chen X, Yang F, Yang Z, Zhu X, Wang J. Hao Q, et al. Oncotarget. 2016 Apr 19;7(16):22271-84. doi: 10.18632/oncotarget.7926. Oncotarget. 2016. PMID: 26967244 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- GlyGen glycoinformatics resource
Research Materials
- NCI CPTC Antibody Characterization Program